News & Updates

Show Multimedia Only

EzPAP device bests noninvasive ventilation for hypercapnic COPD exacerbations

24 Oct 2025 by

In the treatment of patients with mild-to-moderate hypercapnic exacerbations of chronic obstructive pulmonary disease (COPD), the EzPAP positive airway pressure device works better than noninvasive ventilation at improving oxygen saturation levels and correcting respiratory acidosis, as shown in a study.

EzPAP device bests noninvasive ventilation for hypercapnic COPD exacerbations

24 Oct 2025

Azole antifungals safe, effective in patients on midostaurin for FLT3 AML

24 Oct 2025

The use of azole antifungal medications concurrently or sequentially with midostaurin is both safe and effective for patients with newly diagnosed FMS-like tyrosine kinase 3 mutated (FLT3m) acute myeloid leukaemia (AML), reports a study.

Azole antifungals safe, effective in patients on midostaurin for FLT3 AML

24 Oct 2025

Volumetric measurements predict aortic complications after ATAAD surgery

24 Oct 2025 by

Monitoring the progress of and predicting postsurgical complications in patients who underwent acute type A aortic dissection (ATAAD) repair is possible with the use of postoperative CT volumetric measurements, suggests a Singapore study.

Volumetric measurements predict aortic complications after ATAAD surgery

24 Oct 2025

High incidence of chemo-related ADRs noted in multiple myeloma patients

24 Oct 2025

A single-institution study has found a notably high incidence of chemotherapy-related adverse drug reactions (ADRs) in patients with multiple myeloma.

High incidence of chemo-related ADRs noted in multiple myeloma patients

24 Oct 2025

Oral blarcamesine delivers long-term benefit in early AD

24 Oct 2025 by

Findings from the phase IIb/III ATTENTION-AD study reflect the continued benefit of oral blarcamesine in individuals with early Alzheimer’s disease (AD) after receiving the drug continuously for up to 4 years.

Oral blarcamesine delivers long-term benefit in early AD

24 Oct 2025

Migraine linked to hypertension in teens

24 Oct 2025

Adolescents with migraine appear to have an increased likelihood of hypertension, as suggested in a large cross-sectional study.

Migraine linked to hypertension in teens

24 Oct 2025

Blinatumomab for B-cell precursor ALL: From hospital to home

24 Oct 2025 by

Blinatumomab, a bispecific T cell–engager antibody administered as a continuous intravenous (IV) infusion, has several indications in B-cell precursor acute lymphoblastic leukaemia (ALL). Traditionally, in Hong Kong, patients receiving blinatumomab are hospitalized for 28-day treatment cycles. In an interview with MIMS Oncology, Dr Carol Cheung, Specialist in Haematology & Haematological Oncology, and clinical pharmacist Ms Kitty Leung shared insights into how a proactive outpatient infusion protocol at a local hospital has enabled patients to receive blinatumomab at home. They discussed how home infusion of blinatumomab works, along with its risks, challenges, and benefits for both patients and healthcare providers.

Blinatumomab for B-cell precursor ALL: From hospital to home

24 Oct 2025

PHQ, HADS deemed acceptable for poststroke depression screening in Singapore

23 Oct 2025 by

Both the Patient Healthcare Questionnaire (PHQ) and the Hospital Anxiety and Depression Scale (HADS) are useful for identifying stroke survivors with depression in Singaporean inpatient rehabilitation care settings, as shown in a study.